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A B S T R A C T
Cocaine increases dopamine concentration in the nucleus accumbens through competitive binding to the
dopamine transporter (DAT). However, it also increases the frequency of dopamine release events, a ﬁnding
that cannot be explained by action at the DAT alone. Rather, this eﬀect may be mediated by cocaine-induced
modulation of brain regions that project to dopamine neurons. To explore regional contributions of cocaine to
dopamine signaling, we administered cocaine to the lateral or fourth ventricles and compared the eﬀects on
dopamine release in the nucleus accumbens evoked by electrical stimulation of the ventral tegmental area to
that of systemically-delivered cocaine. Stimulation trains caused a sharp rise in dopamine followed by a slower
return to baseline. The magnitude of dopamine release ([DA]max) as well as the latency to decay to ﬁfty percent
of the maximum (t(1/2); index of DAT activity) by each stimulation train were recorded. All routes of cocaine
delivery caused an increase in [DA]max; only systemic cocaine caused an increase in t(1/2). Importantly, these
data are the ﬁrst to show that hindbrain (fourth ventricle)-delivered cocaine modulates phasic dopamine
signaling. Fourth ventricular cocaine robustly increased cFos immunoreactivity in the nucleus of the solitary
tract (NTS), suggesting a neural substrate for hindbrain cocaine-mediated eﬀects on [DA]max. Together, the
data demonstrate that cocaine-induced eﬀects on phasic dopamine signaling are mediated via actions
throughout the brain including the hindbrain.
1. Introduction
The development of drug addiction begins with the initial reinfor-
cing eﬀects of drugs that involve brain dopamine. While diﬀerent
classes of addictive drugs vary in their primary pharmacological
mechanisms (Luscher and Ungless, 2006), they all share an acute
eﬀect of increasing dopamine concentration in the striatum, particu-
larly in the nucleus accumbens (NAc) (Di Chiara and Imperato, 1988;
Cheer et al., 2007), an eﬀect essential for reinforcement. Continued use
of addictive substances and therefore enhanced dopaminergic signaling
can lead to physiological changes within the striatum that contribute to
the perseverant conditioned responses seen in drug addiction. The
psychostimulant cocaine exerts its reinforcing eﬀects through its
actions in the central nervous system. Indeed, rats generalize the
eﬀects of systemic cocaine to central nervous system delivery (Wood
et al., 1987) and will self-administer cocaine directly to dopamine
terminals regions (McBride et al., 1999). Cocaine must also enter the
central nervous system to evoke dopamine signaling in the NAc
(Porter-Stransky et al., 2011). The primary mechanism of cocaine
action on NAc dopamine concentration is through its ability to block
the reuptake of dopamine by the dopamine transporter (DAT) (Giros
et al., 1996; McElvain and Schenk, 1992). Aspects of cocaine reward
are dependent on its binding to the DAT (Chen et al., 2006). Consistent
with this mechanism, systemic cocaine increases the magnitude and
decreases the decay rate of electrically-evoked, phasic increases in
extracellular dopamine (Wu et al., 2001).
Systemic cocaine also increases the magnitude and duration of
spontaneously occurring dopamine release events termed ‘transients’
(Heien et al., 2005; Aragona et al., 2008). Interestingly, it also
increases transient frequency - a result that would not be predicted
based on reuptake blockade alone (Aragona et al., 2008; Covey et al.,
2014). These transients can become time-locked to reward predictive
stimuli (Stuber et al., 2008; Aragona et al., 2009) and are correlated
with conditioned approach to reward predictive cues (Stuber et al.,
2008; Cone et al., 2016; Aragona et al., 2009). They are thought to be
critical for incentivizing goal-directed behavior (Hamid et al., 2016)
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and thus play a critical role in the development of addictive behaviors.
Dopamine transients induced by cocaine are linked to the excitability of
dopamine neurons, as inactivation of the ventral tegmental area (VTA;
the site of dopamine cell bodies projecting to the NAc) by lidocaine
abolishes cocaine-induced NAc transient activity (Aragona et al., 2008;
Owesson-White et al., 2012). Furthermore, recent work has suggested
that cocaine enhances excitatory inputs to dopamine neurons. Cocaine
increases the ﬁring rate of VTA dopamine neurons following cocaine
administration (Mejias-Aponte et al., 2015). In addition, phasic
dopamine release caused by intravenous cocaine is dependent on
excitatory noradrenergic receptors in the VTA (Goertz et., al, 2015).
Thus, accumulating evidence suggests that cocaine increases excitatory
drive to dopamine neurons. However, VTA dopamine neurons receive
inputs from cocaine-sensitive sites throughout the neuraxis and it
remains unclear which regions of the brain aﬀected by cocaine delivery
contribute to the increase in the excitability of dopamine neurons and
NAc dopamine release.
To explore regionally selective actions of cocaine on phasic dopa-
mine signaling in the NAc, we delivered cocaine to either the lateral or
fourth ventricle at a dose that establishes a conditioned place pre-
ference (Morency and Beninger, 1986) and generalizes to a self-
administered systemic dose when delivered to the lateral ventricle
(Wood et al., 1987). We sampled dopamine concentration in the NAc
using fast-scan cyclic voltammetry (FSCV) and compared the eﬀects of
centrally-administered cocaine on dopamine release electrically-evoked
by stimulation of the VTA to those of systemic delivery. We measured
the magnitude of electrically-evoked dopamine release [which is
inﬂuenced by both dopamine neuron excitability (Van Zessen et al.,
2012) and the rate of dopamine reuptake] and the latency for
dopamine to decay from peak concentration (an index of reuptake
(Yorgason et al., 2011)). Additionally, immunohistochemistry was
performed to determine if VTA projections from the caudal brainstem
could contribute to eﬀects of fourth ventricular cocaine on dopamine
signaling. Collectively, the results support the hypothesis that cocaine
acts widely throughout the central nervous system to inﬂuence
dopamine signaling through multiple mechanisms but also point to a
surprising role for the caudal brainstem.
2. Results
For FSCV experiments, histological analyses indicated that all
measurements were made in the NAc core (Fig. 1A). Data were
normalized to average of the 3 baseline measurements and expressed
as percent change for all subjects. It should be noted, though, that there
were no diﬀerences between experimental groups in any experiment
prior to pharmacological manipulations. In addition, we conﬁrmed that
infusion cannula were placed in either the lateral or fourth ventricle
(see Fig. 1B and C for representative examples).
2.1. Systemic cocaine potentiates the magnitude and duration of
electrically-evoked dopamine release events in the NAc
Cocaine (2.5 mg/kg; IP) reliably increased the magnitude of
electrically-evoked dopamine release events in the NAc. The eﬀects of
drug treatment on magnitude are represented by Fig. 2A where the
average maximal evoked dopamine release ([DA]max) at each of the 23
time points is expressed as percent change from baseline. A two-way
ANOVA revealed that the magnitude of electrically-evoked dopamine
release varied as a function of time, [F(1, 23)=3.60, p < 0.001], as well
as a function of drug treatment, [F(1, 23)=19.45, p < 0.001]. More
importantly, a signiﬁcant interaction was found such that cocaine-
treated rats showed an increase in [DA]max at speciﬁc time points
relative to saline-treated rats, [F(1, 23)=9.26, p < 0.001]. Post-hoc
Bonferroni-corrected t-tests revealed diﬀerences between cocaine and
saline treatment beginning at 12 min post-drug administration and
continuing through the end of the recording period.
Systemic cocaine also reliably increased the duration of electrically-
evoked dopamine release events across time. Duration was calculated
as the latency for the signal to decay to half maximum (t(1/2)) and is
expressed as a percent change from baseline in Fig. 2B. The duration of
dopamine release events varied both as a function of time, [F(1, 23)
=7.11, p < 0.001], as well as by drug treatment, [F(1, 23)=32.02, p <
Fig. 1. Histological veriﬁcation of FSCV recordings and ventricular infusions. (A). Summary of FSCV recording sites in the NAc core categorized by experimental treatment. Black dots
indicate the location of the electrolytic lesion created in each animal. (B). Representative image of histological veriﬁcation of lateral ventricular infusions using India ink. (C).
Representative image of histological veriﬁcation of fourth ventricular infusions using India ink.
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0.001]. As with magnitude, a signiﬁcant interaction was found such
that cocaine-treated rats showed an increase in duration of release
events at speciﬁc time points relative to saline-treated rats, [F(1, 23)
=6.98, p < 0.001]. Post-hoc analyses revealed that diﬀerences between
cocaine- and saline-injected rats emerged at 12 min (p < 0.05) and
remained signiﬁcant through the remainder of the 60 min post-
injection session (p < 0.05). Since signiﬁcant diﬀerences emerged at
12 min (denoted by rectangle in Fig. 2A and B) following injection, the
average dopamine spike evoked during the ﬁnal baseline stimulation is
plotted with the average dopamine spike evoked 12 min after injection
for saline- (top) and cocaine- (bottom) injected rats in Fig. 2C. A
summary of both magnitude and duration eﬀects at the 12 min time
point for both systemic saline and cocaine groups is depicted in
Fig. 2D.
2.2. Lateral ventricular cocaine potentiates the magnitude but not
duration of electrically-evoked dopamine release events in the NAc
Lateral ventricular cocaine (50 μg/1 μl) reliably increased the
magnitude of electrically-evoked dopamine release. The average [DA]
max at each time point is represented as percent change from baseline
for both saline- and cocaine-treated rats in Fig. 3A. Analysis revealed a
main eﬀect of both time, [F(1, 23)=5.80, p < 0.001], and drug treat-
ment [F(1, 23)=12.50, p < 0.01]. Additionally, a signiﬁcant interaction
was found where animals receiving lateral ventricular cocaine showed
an increase of magnitude across time compared to saline-treated
animals, [F(1, 23)=4.86, p < 0.001]. Post-hoc analyses revealed this
interaction was signiﬁcant between the 6 min (p < 0.05) and 30 min (p
< 0.05) time points. Therefore lateral ventricular cocaine increases the
magnitude of electrically-evoked dopamine release in NAc in a more
rapid, yet shorter-lived manner as compared to systemic cocaine.
Unlike the eﬀects on magnitude, lateral ventricular cocaine failed to
signiﬁcantly aﬀect the duration of electrically-evoked dopamine release
events. The average t(1/2) is expressed as percent change from baseline
for each time point in Fig. 3B. While statistical analyses revealed a
main eﬀect of time, [F(1, 23)=4.15, p < 0.001], there was no signiﬁcant
eﬀect of drug treatment, [F(1, 23)=1.34, p=n.s.], nor was there an
interaction of cocaine exposure across time, [F(1, 23)=1.33, p=n.s.]. As
the eﬀects of systemic cocaine were ﬁrst signiﬁcant 12 min after drug
administration, this time point was used for all experimental groups to
compare diﬀerences in both magnitude and duration of electrically-
evoked dopamine release events. Average dopamine spikes comparing
the evoked change in dopamine concentration during the ﬁnal baseline
sample and 12 min post-treatment from both saline (top) and cocaine
(bottom) treated rats are illustrated in Fig. 3C. A summary for both
[DA]max, and t(1/2) is represented in Fig. 3D as the average percent
change from baseline at 12 min post-treatment for both saline- and
cocaine-injected rats.
2.3. Fourth ventricular cocaine potentiates the magnitude but not
duration of electrically-evoked dopamine release events in the NA
Fourth ventricular cocaine reliably increased the magnitude of
electrically-evoked dopamine release events in the NAc. The eﬀect of
cocaine, as compared to saline, on magnitude can be seen in Fig. 4A,
where [DA]max is represented as a percent change from baseline
across each time point recorded. Statistical analyses revealed a main
eﬀect of time, [F(1, 23) =6.39, p < 0.001], as well as a main eﬀect of
Fig. 2. Systemic cocaine potentiates both magnitude and duration of electrically-evoked dopamine release events in the NAc. (A). Average [DA]max at each of the 23 time points
expressed as percent change from baseline. Symbols represent means and error bars represent ± 1 standard error of the mean (SEM) for saline- (black ﬁlled circle and line) and cocaine-
(red ﬁlled squares and line) injected rats. (B). Average latency for the signal to decay to half maximum (t(1/2)) expressed as a percentage of baseline. Conventions are identical to those of
A. (C). Average change in dopamine concentration evoked during the ﬁnal baseline stimulation (black trace) is plotted with the average change in dopamine concentration evoked 12 min
after injection (red trace) for saline (top) and cocaine (bottom) injected rats. (D). Summary of average [DA] max and t(1/2) at 12 min post-injection expressed as percent change. Bars
represent means and error bars represent ± 1 SEM for saline (dark gray) and cocaine (red) treatment.
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drug treatment, [F(1, 23) =6.15, p < 0.05]. These eﬀects were moder-
ated by a signiﬁcant interaction, [F(1, 23) =5.11, p < 0.001], such that
fourth ventricular cocaine increased the magnitude of dopamine
release events over time compared to saline-treated animals. Post-
hoc Bonferroni t-tests proved revealed signiﬁcant diﬀerences from
6 min following drug administration to 21 min. Therefore, similar to
lateral ventricular cocaine delivery, cocaine administered to the fourth
ventricle had a more rapid, yet shorter-lived eﬀect on the magnitude of
electrically-evoked dopamine in the NAc compared to systemic cocaine.
Fourth ventricular, like lateral ventricular, cocaine failed to cause a
signiﬁcant eﬀect on the duration of electrically-evoked dopamine
release. Average t(1/2) is represented as a percent change from
baseline across time in Fig. 4B. Analyses revealed a main eﬀect of
time, [F(1, 23)=2.52, p < 0.001] but no signiﬁcant main eﬀect of drug
treatment, [F(1, 23)=1.65, p= n.s.] or interaction of drug treatment
over time on duration, [F(1, 23)=0.907, p=n.s.]. Thus, while fourth
ventricular cocaine signiﬁcantly modulates the magnitude of electri-
cally-evoked dopamine release in the NAc, it has no signiﬁcant eﬀect on
the duration of such events. Average dopamine spikes for both cocaine-
and saline-treated animals at the ﬁnal baseline recording and 12 min
post-drug administration are illustrated in Fig. 4C. Additionally, a
summary of both fourth ventricular saline and cocaine eﬀects on [DA]
max and t(1/2) at the 12 min time point are represented in Fig. 4D.
2.4. Fourth ventricular cocaine induces cFos in the NTS
To investigate potential inputs to the VTA that might be responsible
for the augmented evoked dopamine release following fourth ventri-
cular delivery of cocaine, we triple-labeled cells in the nucleus of the
solitary tract (NTS) for cFos, tyrosine hydroxylase (TH) and VTA-
injected ﬂuorogold (FG; a monosynaptic retrograde tracer to identify
VTA-projecting cells). The NTS was investigated due to recently
identiﬁed, monosynaptic connections with the VTA (Alhadeﬀ et al.,
2012; Mejias-Aponte et al., 2009) as well as its responsiveness to
systemic cocaine (Buﬀalari and Rinaman, 2014). At each level of the
NTS examined (−14.2, −13.8, and −13.4 mm posterior to bregma),
there were statistically signiﬁcant increases in cFos immunoﬂuores-
cence in rats that received fourth ventricular cocaine vs. saline (all ps <
0.05). Fig. 5 provides representative images of FG injection sites in the
VTA (Fig. 5A), cFos expression in the NTS (Fig. 5B) as well as co-
localization of cFos, TH and FG in the NTS (Fig. 5C) of cocaine- vs.
saline-treated rats. Average cell counts and co-localization percentages
for each level of the NTS are provided below and in Table 1.
In the NTS at the approximate level of bregma −14.2 mm, there
were 5.2 ± 1.0 cFos-expressing cells per unilateral brain section in
fourth ventricular cocaine-treated rats compared to 0.11 ± 0.11 cFos-
expressing cells in fourth ventricular saline-treated rats (p < 0.05).
While diﬀerences in cFos were apparent, NTS sections did not diﬀer
with respect to the number of either TH or FG labeled cells (cocaine-
vs. saline-treated rats all ps=ns). In fourth ventricular cocaine-treated
rats, 35.9 ± 8.6% of cFos cells co-expressed TH, 11.9 ± 7.0% of cFos
cells co-expressed FG, and 5.4 ± 2.5% of cFos cells co-expressed both
TH and FG.
In the NTS at approximately bregma −13.8 mm level, there were
13.4 ± 2.2 cFos-expressing cells per unilateral brain section in fourth
ventricular cocaine-treated rats compared to 0.33 ± 0.17 cFos-expres-
sing cells in fourth ventricular saline-treated rats (p < 0.01). There were
no diﬀerences with respect to FG- or TH-positive cells (all ps=n.s.). In
Fig. 3. Lateral ventricular cocaine potentiates the magnitude but not duration of electrically-evoked dopamine release events in the NAc. (A). Average [DA]max at each of the 23 time
points and expressed as percent change from baseline. Symbols are the means and error bars represent ± 1 SEM) for saline (black ﬁlled circle and line) and cocaine (red ﬁlled squares
and line) injected rats. (B). Average latency for the signal to decay to half maximum (t(1/2)) expressed as a percentage of baseline. Conventions are identical to those of Fig. 2A. (C).
Average change in dopamine concentration evoked during the ﬁnal baseline stimulation (black trace) is plotted with the average change in dopamine concentration evoked 12 min after
injection (red trace) for saline (top) and cocaine (bottom) injected rats. (D). Summary of average [DA] max and t(1/2) at 12 min post-injection expressed as percent change. Bars
represent means and error bars represent ± 1 SEM for saline (dark gray) and cocaine (red) treatment.
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fourth ventricular cocaine-treated rats, approximately 43.2 ± 4.7% of
cFos cells co-expressed TH, 5.1 ± 1.6% of cFos cells co-expressed FG,
and 2.6 ± 0.9% of cFos cells co-expressed both TH and FG.
More anterior in the NTS at approximately bregma −13.4 mm,
there were 15.0 ± 3.1 cFos-expressing cells per unilateral brain section
in fourth ventricular cocaine-treated rats compared to 1.3 ± 1.1 cFos-
expressing cells in fourth ventricular saline-treated rats (p < 0.05).
There were no diﬀerences with respect to FG- or TH-positive cells (all
ps=n.s.). In fourth ventricular cocaine-treated rats, approximately 34.3
± 3.7% of cFos cells co-expressed TH, 3.2 ± 1.5% of cFos cells co-
expressed FG, and 1.9 ± 0.9% of cFos cells co-expressed both TH and
FG.
3. Discussion
Mesolimbic dopamine signaling is essential to the initial reinforcing
properties of drugs of abuse and the formation of drug addiction. The
primary mechanisms by which diﬀerent classes of addictive drugs
potentiate dopamine signaling have largely been elucidated, however
there remain additional eﬀects on dopamine action that cannot be
explained by their traditional actions alone. This study examined the
eﬀects of cocaine acting in diﬀerent parts of the neuraxis on NAc
dopamine signaling to uncover possible alternative drug targets. We
found that cocaine administered to the fourth ventricle – which
restricted cocaine action to the hindbrain (Hayes et al., 2009) –
potentiated the magnitude ([DA] max) of electrically evoked dopamine
release in the NAc. This eﬀect occurred in the absence of an eﬀect on
the duration (t(1/2)) of evoked release and hence cannot be explained
by dopamine reuptake blockade – the traditional explanation for
cocaine action on dopamine signaling. The rapid time course of this
eﬀect and its lack of eﬀect on duration of evoked dopamine release
events in the NAc were almost identical to that of lateral ventricular
cocaine. Both centrally administered eﬀects of cocaine were compared
to systemic delivery (2.5 mg/kg) where, not surprisingly, we observed
an eﬀect of cocaine on both magnitude and duration of evoked
dopamine release events. Systemic cocaine delivery followed a slightly
longer onset yet prolonged time course overall.
Previous work has shown that cocaine increases both the magnitude
and duration of electrically-evoked dopamine release in the NAc in
both slice preparations (Jones et al., 1995a, 1995b) and in vivo when
given systemically (Suaud-Chagny et al., 1995; Jones et al., 1995a;
Heien et al., 2005). Therefore our results from systemic cocaine
exposure were expected, however, they served as a critical baseline
comparison for our experiments with centrally-delivered cocaine.
Cocaine is traditionally thought to increase extracellular dopamine by
acting on the DAT and blocking the reuptake of dopamine (Torres
et al., 2003; Cragg and Rice, 2004). DAT blockade could explain both
eﬀects observed on evoked-release: as dopamine is released with each
stimulation pulse, it is simultaneously cleared from the extracellular
space by reuptake. Thus, DAT blockade could account both for the
enhanced magnitude of release as well as reduced decay rate.
Lateral ventricular cocaine increased the magnitude of evoked
dopamine release without altering decay rate. DAT blockade, therefore,
is an insuﬃcient explanation for this result. Rather, since electrical
stimulation of the VTA is thought to drive dopamine release, in large
part, via glutamate action on dopamine cell bodies (Negus and Miller,
2014), the data suggest that lateral ventricle cocaine enhanced
dopamine cell excitability, either through changes to dopamine neu-
Fig. 4. Fourth ventricular cocaine potentiates the magnitude but not duration of electrically-evoked dopamine release events in the NAc. (A). Average [DA]max at each of the 23 time
points and expressed as percent change from baseline. Symbols are the means and error bars represent ± 1 SEM for saline (black ﬁlled circle and line) and cocaine (red ﬁlled squares and
line) injected rats. (B). Average latency for the signal to decay to half maximum (t(1/2)) expressed as a percentage of baseline. Conventions are identical to those of Fig. 2A. (C). Average
change in dopamine concentration evoked during the ﬁnal baseline stimulation (black trace) is plotted with the average change in dopamine concentration evoked 12 min after injection
(red trace) for saline (top) and cocaine (bottom) injected rats. (D). Summary of average [DA] max and t(1/2) at 12 min post-injection expressed as percent change. Bars represent means
and error bars represent ± 1 SEM for saline (dark gray) and cocaine (red) treatment.
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rons themselves on an increase in excitatory drive from aﬀerents.
Indeed, cocaine increases the burst ﬁring of many VTA dopamine
neurons (Koulchintsky et al., 2012; Mejias-Aponte et al., 2015) and
rapidly (e.g. within minutes) enhances the excitability of dopamine
neurons via direct action on the VTA by enhancing N-methyl-D-
aspartate (NMDA) receptor currents (Schilström et al., 2006; Argilli
et al., 2008). Cocaine also blocks the norepinephrine (NE) transporter.
NE and its receptors mediate a variety of cocaine-stimulated behaviors
(Schroeder et al., 2013; Schmidt and Weinshenker, 2014) and are
critical mediators of cocaine-induced increases in NAc phasic dopa-
mine signaling (Goertz et al., 2015). Thus, it is possible that lateral
ventricular cocaine potentiated evoked dopamine release through
direct action within the VTA.
The mechanisms mediating eﬀects of fourth ventricular cocaine are
less clear. Fourth ventricular infusions of low volume act on the peri-
ventricular hindbrain parenchyma e.g., (Hayes et al., 2009) and thus
direct action of fourth ventricular-injected cocaine in the VTA is
unlikely. Instead, the data suggest that cocaine activation of hindbrain
neurons projecting to the VTA may enhance the excitatory drive to
dopamine neurons. Geisler et al. found that systemic cocaine strongly
activated VTA-projecting ventromedial mesopontine tegmentum neu-
rons (Geisler et al., 2008). While there was some overlap in cFos
Fig. 5. Fourth ventricular cocaine induces cFos in the NTS. (A). Representative image of FG injection into the VTA. White dashed circles represent the VTA and SNc at the level of
−5.2 mm relative to bregma, respectively. (B). Representative image of cFos labeling in the NTS at the level of −13.4 mm relative to bregma of fourth ventricular cocaine-treated rats. (C).
Representative image of cFos labeling in the NTS at the level of −13.4 mm relative to bregma of fourth ventricular saline-treated rats. (D). Representative image of colocalization of cFos
(red), TH (green), and FG (blue) labeling in the NTS of fourth ventricular cocaine-treated rats. (E). Representative image of colocalization of cFos (red), TH (green), and FG (blue)
labeling in the NTS of fourth ventricular saline-treated rats. Horizontal scale bar on each panel illustrates scale.
Table 1
Average cell counts and colocalization percentages represented at each level of the NTS
by experimental treatment.
NTS
Coordinates
Bregma −14.2 mm Bregma −13.8 mm Bregma −13.4 mm
Treatment Cocaine Saline Cocaine Saline Cocaine Saline
cFos *5.2 (1.0) 0.11
(0.11)
*13.4 (2.2) 0.33
(0.17)
*15.0 (3.1) 1.3 (1.1)
TH 13.9 (1.4) 13.2
(2.4)
13.7 (1.0) 11.5
(1.9)
11.8 (1.5) 11.1 (0.8)
FG 11.3 (1.4) 11.1
(1.4)
9.4 (2.2) 10.2
(1.4)
6.5 (1.2) 7.0 (2.3)
% cFos w/
TH
35.9 (8.6) 11.1
(11.1)
43.2 (4.7) 0 (0) 34.3 (3.7) 1.2 (1.2)
% cFos w/
FG
11.9 (7.0) 0 (0) 5.1 (1.6) 0 (0) 3.2 (1.5) 0 (0)
% cFos w/
TH &
FG
5.4 (2.5) 0 (0) 2.6 (0.9) 0 (0) 1.9 (0.9) 0 (0)
Note: Cell count and colocalization averages represented as mean ± SEM.
* =p < 0.05.
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expression with areas that send cholinergic and glutamatergic aﬀerents
to the VTA, the overlap was relatively small. Moreover, the exact
phenotype of these brainstem-VTA projection neurons could not be
identiﬁed. However, additional regions of the hindbrain [i.e. parabra-
chial nucleus (Grabus et al., 2004) and NTS (Grabus et al., 2004;
Buﬀalari and Rinaman, 2014)] that project to the VTA express cFos in
response to systemic cocaine. As the NE neurons of the A2 region of the
NTS project to the VTA and, as previously mentioned, NE release in the
VTA appears critical in mediating cocaine-induced dopamine signaling
in the NAc, these neurons are of particular interest.
We explored the possibility that cocaine action in the NTS activates
a population of NE neurons projecting to the VTA using immunohis-
tochemistry. Fourth ventricular delivery of cocaine signiﬁcantly ele-
vated cFos expression in the NTS relative to vehicle delivery. Many of
these neurons were positive for TH. However, very few cocaine-
activated neurons projected directly to the VTA and even fewer TH-
positive neurons projected directly to the VTA. Thus, the cFos data
suggest that hindbrain cocaine engages NTS NE neurons, but these
neurons likely do not directly potentiate VTA dopamine neuron
excitability. Still, the failure to observe cFos in VTA-projecting TH-
positive neurons should not be taken as an indication of the absence of
a direct projection. cFos immunohistochemistry is used as a proxy for
neuronal activation, however there are limitations to this approach. For
example, this strategy provides little information about the time course
of activation of NTS neurons following fourth ventricular cocaine
administration. Nevertheless, our data highlight the NTS as a hind-
brain substrate potentially involved in fourth ventricular cocaine's
eﬀects on electrically-evoked DA release. The speciﬁc mechanisms by
which NTS neurons communicate with mid- and forebrain structures
to inﬂuence dopamine signaling should be investigated in future
studies. Recently, NTS neurons that produce glucagon-like peptide 1
(GLP-1) were shown to project directly to the VTA (Alhadeﬀ et al.,
2012). GLP-1 has been implicated in modulating cocaine self-admin-
istration (Schmidt et al., 2016; Sørensen et al., 2015), cocaine reward
(Graham et al., 2013) as well as the excitability of VTA neurons
(Mietlicki-Baase et al., 2013). While our data support a role for the
caudal brainstem and the NTS speciﬁcally in cocaine-potentiated
dopamine signaling, identifying cell types and their path to the VTA
remains an important future direction.
While cocaine clearly has eﬀects in the periphery (Wise et al.,
2008), cocaine must enter the brain to exert eﬀects on dopamine
signaling (Porter-Stransky et al., 2011) which, in turn, is thought to be
critical for cocaine's reinforcing properties. Our data contribute to a
growing recognition that cocaine acts throughout the central nervous
system to increase dopamine signaling. Given that fourth ventricular
cocaine activates NTS neurons and potentiates evoked dopamine
release in the NAc, we now can include the caudal brainstem as
another neural substrate upon which cocaine exerts its eﬀects on
dopamine signaling. The caudal brainstem and NTS are emerging as a
critical node for food reinforcement (Alhadeﬀ and Grill, 2014; Kanoski
et al., 2014). The present data extend these ﬁndings to suggest that the
NTS may also play a role in drug reinforcement through its ability to
tune phasic dopamine signaling in the NAc.
4. Experimental procedures
4.1. Subjects
For experiments involving dopamine measurements, forty-two
experimentally naïve, male Sprague-Dawley rats (300–400 g at testing,
Charles River Laboratories, Chicago, IL), individually housed in plastic
cages in a temperature and humidity controlled room on a 12:12
light:dark cycle (lights on at 7:00) were used. Experiments were
conducted during the light cycle. Rats were treated according to the
guidelines recommended by the Animal Care Committee of the
University of Illinois at Chicago. For experiments involving immuno-
histochemistry, male Sprague-Dawley rats (250–265 g upon arrival,
Harlan Laboratories, Indianapolis, IN) were individually housed in
hanging metal cages within a temperature and humidity controlled
room on a 12:12 light:dark cycle. All rats had ad libitum access to
pelleted chow (Purina Rodent Chow, 5001) and water. All procedures
conformed to and received approval from the institutional animal care
and use committees of the University of Pennsylvania.
4.2. Fast-scan cyclic voltammetry
For dopamine recordings, rats were anesthetized with intraperito-
neal (IP) urethane (1.5 mg/kg) and prepared for dopamine recordings
using fast-scan cyclic voltammetry (FSCV; see Fortin et al., 2015 for
details). Using the rat brain atlas of Paxinos and Watson (Paxinos and
Watson, 2007) all implants were targeted from bregma. A FSCV guide
cannula (Bioanalytical Systems, West Lafayette, IN) was positioned
dorsal to the NAc (AP: +1.3 mm, ML: +1.0 mm) and a chlorinated
silver (Ag/AgCl) reference electrode was positioned in the contralateral
cortex. Rats receiving intracerebroventricular (ICV) infusions were
implanted with an infusion cannula directed to either the lateral (AP:
−1.0 mm, ML: −3.0 mm, DL: 3.0 mm, angled at 10°) or fourth ventricle
(AP: −11.5 mm, ML: 0.0 mm, DL: −6.5 mm). Stainless steel screws
were inserted in the skull- to secure all implants with dental cement
(Safco Dental Supply Company). A carbon ﬁber microelectrode housed
in a custom-made micromanipulator (UIC Machine Shop, Chicago, IL)
was then inserted into the guide cannula and the electrode was lowered
into the NAc core. Simultaneously, a bipolar stimulating electrode
(Plastics One Inc., Roanoke, VA) was lowered just dorsal to the VTA
(AP: −5.2 mm, ML: +1 mm, DV: −7.0 mm). A train of current pulses
(24 pulses, 60 Hz, 120 µA, 4 ms/pulse) was administered and the
stimulating electrode was lowered in 2 mm increments until dopamine
release was evoked and detected at the carbon-ﬁber electrode in the
NAc. Once maximal dopamine release was evoked (DV: −7.5 to
−8.5 mm), the stimulating electrode was cemented in place. Rats
remained in the stereotaxic frame and experiments were conducted
immediately following surgery.
A carbon-ﬁber recording electrode was loaded into a micromani-
pulator and connected to a head-mounted voltammetric ampliﬁer
attached to a commutator (Crist Instruments, Hagerstown, MD) in a
behavioral chamber (Med-Associates, Inc, St Albans City, VT). The
voltage of the electrode was held at −0.4 V relative to an Ag/AgCl
reference electrode – also connected to the voltammetric ampliﬁer. A
triangular waveform of voltage is then applied, and rapidly (400 V/s)
scanned from a negative (−0.4 V) to a positive (+1.3 V) potential and
back again. The waveform was repeatedly applied at 60 Hz for 20 min,
followed by 10 min at 10 Hz in order to equilibrate the recording
electrode to maintain a stable background current between scans that
can be subtracted out to reveal changes in current due to the oxidation
of dopamine over time.
A train of current pulses (24 pulses, 60 Hz, 120 µA, 4 ms/pulse)
was delivered to the VTA every 3 min. The peak oxidative current due
to dopamine was measured during the 5 s prior to and the 15 s after the
onset of VTA stimulation. Each stimulation evoked a sharp rise in
oxidative current followed by an exponential decay. Current was
converted to concentration after each electrode was calibrated after
use with 1 µm dopamine in a ﬂow injection system (Sinkala et al.,
2012). Peak dopamine concentration ([DA] max) as well as the latency
for dopamine concentration to decay from peak concentration by 50%
(t(1/2)) were determined for each stimulation – the latter being an
index of the rate of reuptake by the DAT (España et al., 2008). Once a
stable baseline of peak release was achieved – as determined by 3
consecutive recordings within 10% of each other and referred to below
as ‘baseline’ – animals received drug or vehicle either systemically (IP)
or centrally to either the lateral or fourth ventricle (ICV). Stimulations
continued for 1 h following drug or vehicle administration.
After experiments were completed a stainless steel electrode was
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lowered through the guide cannula to the depth of the recording site.
Current (1.0 mA, 0.4 s) was applied to create a lesion in order to
localize the recording site. Additionally, 1 μl of india ink (Fischer
Scientiﬁc) was infused into the infusion cannula to verify placement of
either the lateral or fourth ventricle for rats that underwent ICV
manipulations. Brains were immediately extracted and stored in 4%
formalin for at least 24 h before being mounted and sliced in a −20 °C
cryostat (LEICA CM1850). Brain slices were mounted on Poly-L-Lysine
subbed slides (American Master*Tech Scientiﬁc, Inc.) and placements
were veriﬁed and photographed using bright ﬁeld microscopy
(Olympus BX43 Fluorescence Research Microscope).
Data ([DA]max; t(1/2)) from each rate was expressed as a
percentage of the average baseline. Separate statistical comparisons
for each of these measures were conducted for each injection/infusion
site (systemic, lateral ventricle, fourth ventricle). For each measure
within a given injection/infusion site, a 2-way mixed analysis of
variance (ANOVA) – where drug treatment (cocaine vs. saline) was a
between-subjects variable and time (23 samples) was a within-subjects
variable – was calculated. Signiﬁcant interaction terms were further
explored using Bonferroni-corrected t-tests at each time point.
4.3. Immunohistochemistry
Rats (n=9) received intramuscular anesthesia [ketamine (90 mg/
kg; Butler Animal Health Supply, Dublin, OH), xylazine (2.7 mg/kg;
Anased, Shenandoah, IA), and acepromazine (0.64 mg/kg; Butler
Animal Health Supply)] and subcutaneous analgesia (2.0 mg/kg
Metacam; Boehringer Ingelheim Vetmedica, St. Joseph, MO) for all
surgeries. Rats were positioned in a stereotaxic device and a unilateral
cannula was placed above the VTA (coordinates: 0.6 mm lateral from
midline, 5.8 mm posterior to bregma, and 6.4 mm ventral from skull
surface, with the injector aimed 2.0 mm below the end of the guide
cannulae). While under anesthesia and in the stereotaxic device,
animals received a unilateral 200 nl injection of FG in the VTA.
Injectors were left in place for 1 min and then removed. A guide
cannulae was then placed above the fourth ventricle (coordinates:
2.5 mm anterior to occipital and 5.2 mm ventral to skull on midline)
and secured with stainless steel screws and dental cement. FG injection
placements in the VTA were veriﬁed post-mortem; a representative
image of a VTA FG injection is provided in Fig. 5A. Fourth ventricle
cannula placements were functionally conﬁrmed via measurement of
the sympathoadrenal-mediated glycemic response to 5-thio-D-glucose
(210 μg/2 μl artiﬁcial cerebrospinal ﬂuid) injected into the ventricle as
previously reported (Alhadeﬀ et al., 2014; Ritter et al., 1981). A post-
injection increase in blood glucose level of at least 100% from baseline
was necessary for subject inclusion.
Five days following FG injections, rats were injected in the fourth
ventricle with cocaine (50 μg/1 μl; n=6) or saline (n=3). Ninety
minutes post-injection, rats were deeply anesthetized and transcar-
dially perfused with 0.1 M pH 7.4 PBS (Boston Bioproducts, Ashland,
MA) followed by 4% paraformaldehyde (PFA, Boston Bioproducts).
Brains were removed and post-ﬁxed in 4% PFA for 4 h and then stored
in 30% sucrose until brains no longer ﬂoated. Brains were sectioned
coronally (30 µm) at the level of the NTS and collected serially in
triplicate.
Immunohistochemistry (IHC) was conducted according to previous
procedures (Alhadeﬀ et al., 2015). Brieﬂy, sections were washed with
1% sodium borohydride followed by washes with 0.1 M PBS. Brain
sections were incubated in 5% normal donkey serum for 1 h, followed
by an overnight (16 h) incubation with primary antibodies: polyclonal
goat anti-cFos primary antibody (1:2,000, sc-52G; Santa Cruz
Biotechnology, Santa Cruz, CA) and rabbit anti-tyrosine hydroxylase
(TH) primary antibody (1:1,000, 2792S; Cell Signaling, Danvers, MA).
Sections were then washed and incubated with secondary antibodies:
donkey anti-goat AlexaFluor 594 and donkey anti-rabbit AlexaFluor
488 (1:500, Jackson ImmunoResearch Laboratories, West Grove, PA).
FG autoﬂuorescence was detected using a special ﬁlter (C-FL UV-2A;
Nikon Instruments, Melville, NY) on a ﬂuorescence microscope (Nikon
80i; Nikon Instruments).
Brain sections were mounted onto glass slides and coverslipped
using Fluorogel (Electron Microscopy Sciences; Hatﬁeld, PA).
Immunoﬂuorescing neurons were visualized and quantiﬁed using
ﬂuorescence microscopy (Nikon 80i, NIS Elements AR 3.0) at 10×
and 20× magniﬁcation. 8–10 sections per rat were quantiﬁed from the
NTS [2–4 sections each at approximately −14.2, −13.8, and −13.4 mm
posterior to bregma]. These three plate levels were chosen as they
displayed maximal cocaine-induced cFos expression in the NTS. cFos,
FG, and TH cell counts were quantiﬁed unilaterally in all experiments,
as the vast majority of projections from the NTS to VTA are ipsilateral
in nature. Independent samples two-tailed t-tests were used to
compare counts between injection conditions (cocaine vs. saline) where
appropriate.
4.4. Drugs
Cocaine hydrochloride (Sigma-Aldrich, St. Louis, MO) was dis-
solved into its vehicle (saline, 0.9%) to a concentration of 50.0 μg/
1.0 μl saline for ICV manipulations. This dose was chosen based on its
ability to induce a conditioned place preference when given to the
lateral ventricle (Morency and Beninger, 1986). Rats received micro-
injections of 1 μl of this concentration to either the lateral or fourth
ventricle. Rats that received systemic (IP) cocaine received a concen-
tration of 2.5 mg/kg body weight dissolved into saline (0.9%). This
dose was selected to match the magnitude of eﬀect elicited by ICV
cocaine on evoked dopamine release. The monosynaptic retrograde
tracer ﬂuorogold (FG, Fluorochrome, LLC, Denver, CO) was dissolved
to 2% (w/v) in sterile water.
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